Bevacizumab vs Canagliflozin

## Bevacizumab vs Canagliflozin: Overview

This comparison examines the pharmacological differences between **Bevacizumab** and **Canagliflozin**.

## Mechanism of Action

**Canagliflozin**: Selective SGLT2 inhibitor reducing renal glucose reabsorption and lowering blood glucose.

## Pharmacokinetics

**Half-life**: Bevacizumab — N/A; Canagliflozin — 10.6 hours.

## Chemical Properties

**Molecular Formula**: Bevacizumab — N/A; Canagliflozin — C24H25FO5S.

**Molecular Weight**: Bevacizumab — N/A; Canagliflozin — 444.5170 g/mol.

**Type**: Bevacizumab — Antibody; Canagliflozin — Small molecule.